CTOs on the Move

American Bio Medica Corp.

www.abmc.com

 
American Bio Medica Corporation develops, manufactures, and sells immunoassay tests for the immediate point of collection testing (POCT) for drugs of abuse (DOA) in urine and oral fluids. It provides urine-based POCT products that comprise Rapid Drug Screen to detect the presence or absence of 2 to 10 DOA; Rapid ONE for testing the presence or absence of a single DOA; RDS InCup, which detects the presence or absence of 2 to 12 DOA; Rapid TOX that detects the presence or absence of 2 to 10 DOA; and Rapid TOX Cup II for detecting the presence or absence of 2 ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.abmc.com
  • 122 Smith Rd
    Kinderhook, NY USA 12106
  • Phone: 800.227.1243

Executives

Name Title Contact Details

Similar Companies

Enduro Rubber Company

Enduro Rubber Company is a Ravenna, OH-based company in the Manufacturing sector.

KMS Fab

KMS Fab is a Luzerne, PA-based company in the Manufacturing sector.

Waco Chemical

Waco Chemical is a Dalton, GA-based company in the Manufacturing sector.

RADIATOR SPECIALTY COMPANY

RADIATOR SPECIALTY COMPANY is a Indian Trail, NC-based company in the Manufacturing sector.

Verde Science

Verde Science has assembled an impressive team of scientists from highly technical disciplines including Bioprocess Technology, Nanotechnology, Molecular Virology and Immunology, Molecular Biology, Pharmacology and Medical Device Design. Our focus is the discovery of novel drugs and new treatment modalities, as well as cutting edge diagnostic devices and pharmaceutical delivery systems for the treatment of emerging diseases and contemporary medical issues where current treatments either do not exist or are inadequate. Our Research and Development program includes collaboration with our R&D alliance partners which include the Sterkem Group, an integrated pharmaceutical firm based in Mumbai, India; the Institute for Chemical Technology, a Mumbai, India based science and technology university; and our researchers based in India and Canada. We believe that this synergistic and nimble team of highly skilled scientists is the most cost-effective and efficient way to rapidly respond to the increasing array of inadequately addressed contemporary medical issues facing the world community. An initial focus is on developing custom medicinal formulations from cannabinoids and THC compounds for the treatment of specific issues such as migraines, glaucoma, loss of appetite from cancer therapies, and numerous other medical issues. Verde also plans to alpha test innovative growing technologies in India as part of the company’s initiatives.